TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/13/2026
Back to search
Official data from USPTO
TERLIVAZ TERLIPRESSIN FOR INJECTION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
03/15/2026
Trademark type
Combined
Nice classes
5
Filing date
05/04/2020
Registration date
06/13/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/13/2023
Last transaction
03/15/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/12/2022
First use in commerce
10/12/2022
Drawing code
3
Owner type
24
Owner location
Dublin 15, IE
Examiner
REEVES, APRIL ELIZABETH
Law office
N60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Mallinckrodt Hospital Products IP Limited
Representatives
Camille M. Miller Cozen O'Connor
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of hepatorenal syndrome (HRS)
Publications
History of USPTO decisions and trademark events.
41 publications found
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/13/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/13/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/13/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/13/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/13/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/13/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
06/13/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/09/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/07/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/21/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/04/2023
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
12/28/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/21/2022
IUAF
USE AMENDMENT FILED
11/01/2022
EISU
TEAS STATEMENT OF USE RECEIVED
11/01/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/06/2022
EX3G
SOU EXTENSION 3 GRANTED
04/04/2022
EXT3
SOU EXTENSION 3 FILED
04/04/2022
EEXT
SOU TEAS EXTENSION RECEIVED
04/04/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/08/2021
EX2G
SOU EXTENSION 2 GRANTED
10/06/2021
EXT2
SOU EXTENSION 2 FILED
10/06/2021
EEXT
SOU TEAS EXTENSION RECEIVED
10/06/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/21/2021
EX1G
SOU EXTENSION 1 GRANTED
04/19/2021
EXT1
SOU EXTENSION 1 FILED
04/19/2021
EEXT
SOU TEAS EXTENSION RECEIVED
04/19/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/03/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/08/2020
PUBO
PUBLISHED FOR OPPOSITION
09/08/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/19/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/05/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
08/05/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/05/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
08/05/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/05/2020
DOCK
ASSIGNED TO EXAMINER
07/29/2020
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
05/16/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/15/2020
NWAP
NEW APPLICATION ENTERED
05/07/2020
Continuous trademark protection
Get notified about every new filing that threatens TERLIVAZ TERLIPRESSIN FOR INJECTION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.